Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ORIC Pharmaceuticals
Biotech
Oric lays off 20% of workforce in focus on clinical-stage drugs
Oric’s plan to focus resources come with a sting in its tail—the biotech is laying off 20% of its employees to finance the strategy.
James Waldron
Aug 13, 2025 6:20am
Biogen CMO Maha Radhakrishnan joins Sofinnova—Chutes & Ladders
Aug 9, 2024 8:30am
Pfizer boosts ORIC shares with multiple myeloma collaboration
Dec 22, 2022 11:20am
FDA shores up executive team with 2 hires—Chutes & Ladders
Jul 1, 2022 9:30am
ORIC pulls off $120M Wall Street debut, eclipsing $86M goal
Apr 24, 2020 9:30am
Financial volatility be damned: ORIC guns for $86M IPO
Mar 4, 2020 8:22am
